The Children's Oncology Group Foundation Inc

What it reported doing in 2024

The children's oncology group foundation, inc. Enables cog's leadership, comprised of a team of doctors, nurses, laboratory scientists and other allied professionals, the ability to direct the resources raised for childhood cancer research to the areas of highest need and opportunity. The foundation allows philanthropic funds from individual supporters and organizations to go directly to cog to fund its much needed research. In an era of rapid scientific discovery, this direct link allows cog researchers to respond quickly to new discoveries with the greatest potential to benefit children with cancer. The children's oncology group has over 50 active clinical trials open at any given time. These trials include front-line treatment for many types of childhood cancers, studies aimed at determining the underlying biology of these diseases, and trials involving new and emerging treatments, supportive care, and survivorship. The children's oncology group research has turned children's cancer from a virtually incurable disease 50 years ago to one with a combined 5-year survival rate of 80% today. Our goal is to cure all children and adolescents with cancer, reduce the short and long-term complications of cancer treatments, and determine the causes and find ways to prevent childhood cancer. Project: everychild: children's oncology group's project: everychild is our ambitious initiative to find better cures for every type of childhood cancer, no matter how rare. All children with cancer cared for at cog's more than 200 pediatric cancer programs will be able to participate in project: everychild.

Financial Efficiency

• Mission deployment rate: 86.4%; rating input score 86
• Program expense ratio: 94.9%; rating input score 95
• Fundraising efficiency: $151.78 raised per $1 spent on fundraising; rating input score 88; 88th percentile among comparable filings

Transparency & Controls

• Consistency checks: 93.3%; rating input score 93; 14th percentile among comparable filings
• Pay-setting controls: Limited
• Foreign activity oversight: 3 of 8 controls in place; rating input score 38
  • Claims monitoring procedures: Pass
  • Requires narrative reports: Limited
  • Conducts field audits: Pass
  • May suspend future funding: Limited
  • Requires financial reports: Pass
  • Conducts site visits: Limited
  • Requires grant agreements: Limited
  • May require repayment: Limited
• Grant itemization coverage: 98.3%; rating input score 98; 29th percentile among comparable filings
• Major donor itemization: Yes; rating input score 100
• Related-party transparency: Yes; rating input score 100

Accountability

• Independent voting board: 100%; rating input score 100; 66th percentile among comparable filings
• Governance controls: 6 of 8 controls in place; rating input score 75
  • Conflict-of-interest policy: Pass
  • Whistleblower policy: Pass
  • Document-retention policy: Pass
  • CEO compensation review process: NotApplicable
  • Other executive compensation review process: Fail
  • Form 990 shared with the board: Pass
  • Board meeting minutes documented: Pass
  • Audit committee oversight: Fail
  • Independent financial-statement audit: Pass

Sustainability

• Operating margin: 9.4%; rating input score 66; 66th percentile among comparable filings
• Total-asset coverage ratio: 2.37; rating input score 67; 67th percentile among comparable filings
• Liabilities to assets ratio: 0.2; rating input score 58; 58th percentile among comparable filings
• Officer compensation ratio: 1.2%; rating input score 84; 84th percentile among comparable filings

Growth

• Program expense growth: 1.5% per year; rating input score 100; 16th percentile among comparable filings
• Revenue growth: 0.1% per year; rating input score 100; 9th percentile among comparable filings
• Asset growth: 8.5% per year; rating input score 100; 58th percentile among comparable filings